These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18593779)

  • 21. Consequences of antipsychotic medications for the dementia patient.
    Devanand DP; Schultz SK
    Am J Psychiatry; 2011 Aug; 168(8):767-9. PubMed ID: 21813491
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacological Management of Agitation and Aggression in Alzheimer's Disease: A Review of Current and Novel Treatments.
    Liu CS; Ruthirakuhan M; Chau SA; Herrmann N; Carvalho AF; Lanctôt KL
    Curr Alzheimer Res; 2016; 13(10):1134-44. PubMed ID: 27137221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. To treat or not to treat? Managing acute symptoms in an elderly patient with Alzheimer's disease.
    Deegan R; Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2001 Oct; 39(10):12-5. PubMed ID: 11697070
    [No Abstract]   [Full Text] [Related]  

  • 24. Interventions for the treatment of acute agitation.
    Citrome L
    CNS Spectr; 2007 Aug; 12(8 Suppl 11):8-12. PubMed ID: 19317015
    [No Abstract]   [Full Text] [Related]  

  • 25. Very low-dose neuroleptic treatment in two patients with agitation associated with Alzheimer's disease.
    Risse SC; Lampe TH; Cubberley L
    J Clin Psychiatry; 1987 May; 48(5):207-8. PubMed ID: 2883174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agitation in the medically ill elderly.
    Alao AO; Soderberg M; Koss M
    West Afr J Med; 2005; 24(2):171-4. PubMed ID: 16092322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A preliminary study of low dosage zuclopenthixol depot in Alzheimer's disease].
    Robles A; Rodríguez Navarrete FJ; Taboada O; Docasar L; Páramo M; Noya M
    Rev Neurol; 1996 Mar; 24(127):273-5. PubMed ID: 8742387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Before push comes to shove. Managing resident aggression requires a proactive approach.
    Olson JK
    Contemp Longterm Care; 2002 Jul; 25(7):32-3. PubMed ID: 12154621
    [No Abstract]   [Full Text] [Related]  

  • 29. A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD).
    Ballard C; Thomas A; Gerry S; Yu LM; Aarsland D; Merritt C; Corbett A; Davison C; Sharma N; Khan Z; Creese B; Loughlin P; Bannister C; Burns A; Win SN; Walker Z;
    J Am Med Dir Assoc; 2015 Apr; 16(4):316-22. PubMed ID: 25523285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease: an elusive thief.
    Rentz CA
    Nurs Manage; 2008 Jun; 39(6):33-8; quiz 38-9. PubMed ID: 18536588
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of agitation in dementia patients].
    González Salvador MT; Arango López C; Lyketsos CG
    Med Clin (Barc); 1999 Nov; 113(15):592-7. PubMed ID: 10605687
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacological treatment of behavioral symptoms in dementia patients].
    Gabryelewicz T
    Przegl Lek; 2014; 71(4):215-20. PubMed ID: 25141581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can antidepressant medication relieve agitation in Alzheimer's disease?
    Porsteinsson AP; Smith JS; Keltz MA; Antonsdottir IM
    Expert Rev Neurother; 2014 Sep; 14(9):969-71. PubMed ID: 25148535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agitation and aggression in people with Alzheimer's disease.
    Ballard C; Corbett A
    Curr Opin Psychiatry; 2013 May; 26(3):252-9. PubMed ID: 23528917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of atypical antipsychotics in traumatic brain injury.
    Elovic EP; Lansang R; Li Y; Ricker JH
    J Head Trauma Rehabil; 2003; 18(2):177-95. PubMed ID: 12802226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Agitation and other noncognitive abnormalities in Alzheimer's disease.
    Deutsch LH; Rovner BW
    Psychiatr Clin North Am; 1991 Jun; 14(2):341-51. PubMed ID: 1676506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptics and alternative treatments. Management of behavioral symptoms and psychosis in Alzheimer's disease and related conditions.
    Wragg RE; Jeste DV
    Psychiatr Clin North Am; 1988 Mar; 11(1):195-213. PubMed ID: 2898133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group.
    O'Gorman C; Khoury R; Anderson A; Carter M; DiCesare F; Dubé S; Ereshefsky L; Grossberg G; Hefting N; Khan S; Lind S; Moebius H; Shiovitz T; Rosenberg P
    J Prev Alzheimers Dis; 2020; 7(4):274-282. PubMed ID: 32920630
    [No Abstract]   [Full Text] [Related]  

  • 40. A 2023 update on the advancements in the treatment of agitation in Alzheimer's disease.
    Lee D; Clark ED; Antonsdottir IM; Porsteinsson AP
    Expert Opin Pharmacother; 2023 Apr; 24(6):691-703. PubMed ID: 36958727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.